Inhibition of ACAT as a Therapeutic Target for Alzheimer’s Disease Is Independent of ApoE4 Lipidation

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource, 1 online resource.
Language
Englisch

Bibliographic citation
Inhibition of ACAT as a Therapeutic Target for Alzheimer’s Disease Is Independent of ApoE4 Lipidation ; volume:20 ; number:4 ; day:8 ; month:5 ; year:2023 ; pages:1120-1137 ; date:7.2023
Neurotherapeutics ; 20, Heft 4 (8.5.2023), 1120-1137, 7.2023

Creator
Valencia-Olvera, Ana C.
Balu, Deebika
Faulk, Naomi
Amiridis, Aspasia
Wang, Yueting
Pham, Christine
Avila-Munoz, Eva
York, Jason M.
Thatcher, Gregory R. J.
LaDu, Mary Jo
Contributor
SpringerLink (Online service)

DOI
10.1007/s13311-023-01375-3
URN
urn:nbn:de:101:1-2023110610432687060831
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:53 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Valencia-Olvera, Ana C.
  • Balu, Deebika
  • Faulk, Naomi
  • Amiridis, Aspasia
  • Wang, Yueting
  • Pham, Christine
  • Avila-Munoz, Eva
  • York, Jason M.
  • Thatcher, Gregory R. J.
  • LaDu, Mary Jo
  • SpringerLink (Online service)

Other Objects (12)

ApoE4: an emerging therapeutic target for Alzheimer’s disease

ApoE4: an emerging therapeutic target for Alzheimer’s disease

Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease

Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease

Author Correction: Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease

Author Correction: Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease

ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies

ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies

Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules

Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules

Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease

Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease

Thy1-ApoE4/C/EBPβ double transgenic mice act as a sporadic model with Alzheimer’s disease

Thy1-ApoE4/C/EBPβ double transgenic mice act as a sporadic model with Alzheimer’s disease

A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer’s disease mouse model

A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer’s disease mouse model

Lag-time in Alzheimer’s disease patients: a potential plasmatic oxidative stress marker associated with ApoE4 isoform

Lag-time in Alzheimer’s disease patients: a potential plasmatic oxidative stress marker associated with ApoE4 isoform

Apolipoprotein E4 as a Novel Treatment Target for Alzheimer’s Disease

Apolipoprotein E4 as a Novel Treatment Target for Alzheimer’s Disease

Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer’s Disease drug candidate

Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer’s Disease drug candidate

C/EBPβ is a key transcription factor for APOE and preferentially mediates ApoE4 expression in Alzheimer’s disease

C/EBPβ is a key transcription factor for APOE and preferentially mediates ApoE4 expression in Alzheimer’s disease

Related objects